Pulmonary arterial hypertension as the first manifestation in a patient with hereditary hemorrhagic telangiectasia

Internal Medicine

Volumn 53, Issue 20, 2014, Pages 2359-2363

  Ishiwata, Tsukasa ^a   Terada, Jiro ^a   Tanabe, Nobuhiro ^a   Abe, Mitsuhiro ^a   Sugiura, Toshihiko ^a   Tsushima, Kenji ^a   Tada, Yuji ^a   Sakao, Seiichiro ^a   Kasahara, Yasunori ^a   Nakanishi, Norifumi ^b   Morisaki, Hiroko ^b   Tatsumi, Koichiro ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Activin receptor like kinase 1 (ACVRL1); ALK1; Epistaxis; Hereditary hemorrhagic telangiectasia (HHT); Pulmonary arterial hypertension (PAH)

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CARDIOPULMONARY EXERCISE TEST; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HEART FUNCTION; HEMODYNAMICS; HUMAN; HUMAN TISSUE; LUNG FUNCTION TEST; OTORHINOLARYNGOLOGY; PHYSICAL EXAMINATION; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE; THORAX RADIOGRAPHY; DIFFERENTIAL DIAGNOSIS; GENETICS; HYPERTENSION, PULMONARY; MUTATION; NUCLEOTIDE SEQUENCE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MUTATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 84907990657     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.53.2850     Document Type: Article

References (20)

1. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 54: 714-729, 1999.
2. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91: 66-67, 2000.
3. Cottin V, Dupuis-Girod S, Lesca G, et al. Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (renduosler disease). Respiration 74: 361-378, 2007.
4. Girerd B, Montani D, Coulet F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK 1) mutation. Am J Respir Crit Care Med 181: 851-861, 2010.
5. Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363: 852-859, 2004.
6. Dakeishi M, Shioya T, Wada Y, et al. Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 19: 140-148, 2002.
7. Komiyama M, Ishiguro T, Yamada O, et al. Hereditary hemorrhagic telangiectasia in Japanese patients. J Hum Genet 59: 37-41, 2014.
8. Bhatia S, Morrison JF, Bower TC, et al. Pulmonary hypertension in the setting of acquired systemic arteriovenous fistulas. Mayo Clin Proc 78: 908-912, 2003.
9. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343: 931-936, 2000.
10. Harrison RE, Flanagan JA, Sankelo M, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet 40: 865-871, 2003.
11. Abdalla SA, Gallione CJ, Barst RJ, et al. Primary pulmonary hypertension in families with hereditary haemorrhagic telangiectasia. Eur Respir J 23: 373-377, 2004.
12. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43: 97-110, 2006.
13. Trembath RC, Thomson JR, Machado RD, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 345: 325- 334, 2001.
14. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 17: 860-871, 2009.
15. Harradine KA, Akhurst RJ. Mutations of TGFbeta signaling molecules in human disease. Ann Med 38: 403-414, 2006.
16. HHT Mutation Database [Internet]. The University of Utah; 2013. Available from: http://www.hhtmutation.org
17. Fujiwara M, Yagi H, Matsuoka R, et al. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Circ J 72: 127-133, 2008.
18. Sztrymf B, Yaïci A, Girerd B, et al. Genes and pulmonary arterial hypertension. Respiration 74: 123-132, 2007.
19. Machado RD, James V, Southwood M, et al. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation 111: 607-613, 2005.
20. Porteous ME, Curtis A, Williams O, et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet 31: 925- 926, 1994.